ABITEC Corporation launches new ingredients for Lubricant and Metalworking Fluid applications

05/07/2019

Columbus, OH – [May 7, 2019] - ABITEC Corporation continues to add new innovative ingredients that solve the everyday challenges of specialty industrial applications. 

ABITEC is an oleochemical ingredients manufacturer which specializes in functional emulsifiers and surfactants for a range of specialty markets.   ABITEC has recently launched our multifunctional emulsifiers for the lubricant and metalworking fluid market.  Formulators continue to be challenged in bringing more environmentally-friendly solutions to this market while maintaining high performance and quality.  ABITEC’s base fluids and performance enhancing additives for lubricant and metalworking fluids continue to provide formulators a functional and safe alternative to meet their needs. 

ABITEC’s CAPMUL® Multifunctional Emulsifiers offer a wide range of solutions. These emulsifiers are naturally-derived, bio-based ingredients and suitable for use as part of an emulsifier system for industrial applications.  They are GRAS (generally recognized as safe) or direct food additives with little to no eco and aquatic toxicity. They are also safe to manufacture, handle, and dispose of with no warning pictograms needed on labels or regulatory documents.  ABITEC is dedicated to developing high quality ingredients for use globally in a range of diversified specialty applications.


ABITEC’s trademarked specialty lipids include Capmul®, Captex®, Caprol®, Acconon®, Sterotex®, Nutri Sperse®, Hydro~Kote® and Pureco®. Product application areas vary from pharmaceutical, nutritional, industrial and cosmetic products, to the manufacturing of foams, creams, ointments and lotions. These ingredients are produced in the USA under cGMP manufacturing.


About ABITEC Corporation

ABITEC Corporation is part of ABF Ingredients and is headquartered in Columbus, Ohio, USA with two manufacturing sites in the Midwest. ABITEC specializes in the manufacturing and distribution of specialty lipid ingredients for use in the pharmaceutical, nutraceutical, and specialty chemical industries.  In addition, ABITEC offers contract and toll manufacturing services for customers looking to develop and manufacture new oleochemical molecules, blends, or toll-manufacture of  established products. 

About ABF Ingredients

ABF Ingredients is a division of Associated British Foods that focuses on high value ingredients for both food and non-food areas and comprises a range of ingredient companies which include AB Enzymes, Ohly, PGP International, and SPI Pharma.  The group has established strong market positions across a variety of industries, including cereal specialties, enzymes, esters, extruded ingredients, functional polyols, drug delivery systems,  specialty lipids, specialty powders, specialty flours, and yeast extracts worldwide.

 

DOWNLOAD pdf

For further information, please contact:

 

Amanda Coulter

Manager: Marketing Research and Communications

614-429-6453 | [email protected]

www.abiteccorp.com

 

 

Forward-Looking Statements

This press release includes "forward-looking statements" within the meaning of Section 27A of the Securities Act and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements are subject to known and unknown risks and uncertainties, many of which may be beyond our control. We caution you that the forward-looking information presented in this press release is not a guarantee of future events, and that actual events may differ materially from those made in or suggested by the forward-looking information contained in this press release. In addition, forward-looking statements generally can be identified by the use of forward-looking terminology such as "may," "plan," "seek," "comfortable with," "will," "expect," "intend," "estimate," "anticipate," "believe" or "continue" or the negative thereof or variations thereon or similar terminology. Any forward-looking information presented herein is made only as of the date of this press release, and we do not undertake any obligation to update or revise any forward-looking information to reflect changes in assumptions, the occurrence of unanticipated events, or otherwise.